In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Periodontix initiates Phase I/II mouthwash clinical
Demegen and Dow form development collaboration
Demegen Licenses Compounds for Oral Diseases to Pacgen Biopharmaceuticals
DEMEGEN ACQUIRES PAR WORLDWIDE GROUP
Demegen receives antimicrobial peptides patent
Demegen peptides are active against multi-drug resistant bacteria
Demegen receives orphan drug designation for P113D
Incyte to acquire Maxia Pharmaceuticals